121 related articles for article (PubMed ID: 35312295)
41. nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular Carcinoma.
Sridharan B; Devarajan N; Jobanputra R; Gowd GS; Anna IM; Ashokan A; Nair S; Koyakutty M
ACS Appl Bio Mater; 2021 Apr; 4(4):3398-3409. PubMed ID: 35014424
[TBL] [Abstract][Full Text] [Related]
42. Controlling the transverse proton relaxivity of magnetic graphene oxide.
Thapa B; Diaz-Diestra D; Badillo-Diaz D; Sharma RK; Dasari K; Kumari S; Holcomb MB; Beltran-Huarac J; Weiner BR; Morell G
Sci Rep; 2019 Apr; 9(1):5633. PubMed ID: 30948768
[TBL] [Abstract][Full Text] [Related]
43. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
44. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid.
Beyk J; Tavakoli H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2199-2209. PubMed ID: 31309302
[TBL] [Abstract][Full Text] [Related]
45. Non-invasive detection of liver fibrosis: Is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique?
Lucidarme O; Baleston F; Cadi M; Bellin MF; Charlotte F; Ratziu V; Grenier PA
Eur Radiol; 2003 Mar; 13(3):467-74. PubMed ID: 12594548
[TBL] [Abstract][Full Text] [Related]
46. Ultrasmall Europium, Gadolinium, and Dysprosium Oxide Nanoparticles: Polyol Synthesis, Properties, and Biomedical Imaging Applications.
Yue H; Park JY; Chang Y; Lee GH
Mini Rev Med Chem; 2020; 20(17):1767-1780. PubMed ID: 32496986
[TBL] [Abstract][Full Text] [Related]
47. USPIO-PEG nanoparticles functionalized with a highly specific collagen-binding peptide: a step towards MRI diagnosis of fibrosis.
Belkahla H; Antunes JC; Lalatonne Y; Sainte Catherine O; Illoul C; Journé C; Jandrot-Perrus M; Coradin T; Gigoux V; Guenin E; Motte L; Helary C
J Mater Chem B; 2020 Jul; 8(25):5515-5528. PubMed ID: 32490469
[TBL] [Abstract][Full Text] [Related]
48. Facile one-pot fabrication of calcium phosphate-based composite nanoparticles as delivery and MRI contrast agents for macrophages.
Nakamura M; Oyane A; Kuroiwa K; Shimizu Y; Pyatenko A; Misawa M; Numano T; Kosuge H
Colloids Surf B Biointerfaces; 2018 Feb; 162():135-145. PubMed ID: 29190464
[TBL] [Abstract][Full Text] [Related]
49. Retinoic acid-conjugated chitosan/manganese porphyrin ionic-complex nanoparticles for improved T
Tran HP; Jiang Y; Nguyen PH; Kim JJ; Yang SG
J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):382-391. PubMed ID: 34309195
[TBL] [Abstract][Full Text] [Related]
50. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
51. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
Sharifi S; Seyednejad H; Laurent S; Atyabi F; Saei AA; Mahmoudi M
Contrast Media Mol Imaging; 2015; 10(5):329-55. PubMed ID: 25882768
[TBL] [Abstract][Full Text] [Related]
52. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
53. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
54. An Ultrahigh-Field-Tailored T
Wang J; Jia Y; Wang Q; Liang Z; Han G; Wang Z; Lee J; Zhao M; Li F; Bai R; Ling D
Adv Mater; 2021 Jan; 33(2):e2004917. PubMed ID: 33263204
[TBL] [Abstract][Full Text] [Related]
55. LAPONITE®-stabilized iron oxide nanoparticles for in vivo MR imaging of tumors.
Ding L; Hu Y; Luo Y; Zhu J; Wu Y; Yu Z; Cao X; Peng C; Shi X; Guo R
Biomater Sci; 2016 Mar; 4(3):474-82. PubMed ID: 26730414
[TBL] [Abstract][Full Text] [Related]
56. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.
Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J
Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809
[TBL] [Abstract][Full Text] [Related]
57. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
[No Abstract] [Full Text] [Related]
58.
Wang Y; Yu C; Li Y; Bao H; Li X; Fan H; Huang J; Zhang Z
Nanoscale; 2022 Mar; 14(13):5227-5238. PubMed ID: 35315848
[TBL] [Abstract][Full Text] [Related]
59. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
60. Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.
Cowger TA; Tang W; Zhen Z; Hu K; Rink DE; Todd TJ; Wang GD; Zhang W; Chen H; Xie J
Theranostics; 2015; 5(11):1225-32. PubMed ID: 26379788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
